Case report: Diabetic ketoacidosis a rare but serious side-effect of SGLT2 inhibitors Conference over coffee: Menopause, mental health, disordered eating and trauma At a glance factsheet: Tirzepatide for obesity management in people with type 1 diabetes Editorial: What are we actually optimising for
Diabetologia (2011) 54:206776
The compounded GLP-1 program and the Zepbound program are separate products, separate fulfillment pathways, and separate regulatory conversations
By contrast, one residue (F159 4.64 ) on the extracellular loops and six residues (F102 3.33 , I156 4.60 , F182 5.40 , E186 5.44 , F190 5.47 , and F246 6.55 ) on the transmembrane helices were involved in vdW interactions with high frequencies (Fig
What causes nausea for one patient may feel fine for another, depending on genetic factors affecting peptide sensitivity
In Kansas, optimal candidates for semaglutide weight loss measures typically feature a BMI of 30 or greater or possess a BMI of 27 or more accompanied by weight-related medical issues like hypertension, type 2 diabetes, or cholesterol complications
